Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1161

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 3
Chunk 1161
---
CODM, who reviews and evaluates net loss for purposes of assessing performance, making operating decisions, allocating resources and planning
and forecasting for future periods. The measure of segment assets is reported on the balance sheet as total assets.

Note
10 – Subsequent Events

The
Company evaluated events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the
evaluation and transactions, the Company did not identify any subsequent events that would have required adjustment or disclosure in
the Financial Statements.

F-25

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

    JUPITER
    NEUROSCIENCES, INC.

    Dated:
    March 28, 2025
    By:
    /s/
    Christer Rosén

    Christer
    Rosén

    Chairman
    of the Board and Chief Executive Officer

POWER
OF ATTORNEY

Each
person whose signature appears below hereby appoints Christer Rosén as attorney-in-fact with full power of substitution to execute
in the name and on behalf of the registrant and each such person, individually and in each capacity stated below, one or more amendments
to the Annual Report on Form 10-K, which amendments may make such changes in the report as the attorney-in-fact acting deems appropriate
and to file any such amendment to the Annual Report on Form 10-K with the Securities and Exchange Commission. Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.

Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/
    Christer Rosén
     
    Chairman
    of the Board and Chief Executive Officer (principal executive officer)
     
    March 28, 2025
  
    Christer
    Rosén

    /s/
    Saleem Elmasri
     
    Chief
    Financial Officer (principal financial officer and principal accounting officer)